{"Name":"Alector","perma":"alector","BasicInfo":{"funded":"2013-01-01","isClosed":false,"closed":null,"short":"Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel"},"FundingRounds":[{"funding_type":"venture","series":"D","announcedDate":"2016-01-07","moneyRaised":29500000},{"funding_type":"venture","series":"C","announcedDate":"2015-09-16","moneyRaised":32000000},{"funding_type":"venture","series":"a","announcedDate":"2013-10-31","moneyRaised":null}],"Acquisitions":[],"AcquiredBy":null,"IPO":null,"Investments":[],"Products":[],"CurrentTeam":[{"title":"Founder, President & Chief Executive Officer","started":"2014-01-01","ended":null,"firstName":"Arnon","lastName":"Rosenthal"},{"title":"Founder & Chairman of the Board","started":null,"ended":null,"firstName":"Tillman","lastName":"Gerngross"},{"title":"Founder & SAB Member","started":null,"ended":null,"firstName":"Asa","lastName":"Abeliovich"}],"PastTeam":[]}
